logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9493396 B1

PDFFull Text
Date of Patent:
Nov. 15, 2016

Filed:

Aug. 26, 2014

Substituted naphthalene compounds as calcium sensing receptor modulators

Applicant:

Lupin Atlantis Holdings SA, Zug, CH;

Inventors:

Prathap Sreedharan Nair, Maharashtra, IN;

Ganesh Bhausaheb Gudade, Maharashtra, IN;

Mahadeo Bhaskar Tryambake, Maharashtra, IN;

Chetan Sanjay Pawar, Maharashtra, IN;

Sanjeev Anant Kulkarni, Maharashtra, IN;

Venkata P. Palle, Maharashtra, IN;

Rajender Kumar Kamboj, Maharashtra, IN;

Assignee:

LUPIN ATLANTIS HOLDINGS SA, Zug, CH;

Attorney:

Merchant & Gould P.C.

Primary Examiner:

Kristin Vajda

Int. Cl.
CPC ...
C07D 231/12 (2006.01); A61K 31/137 (2006.01); A61K 31/195 (2006.01); A61K 31/415 (2006.01); A61P 13/12 (2006.01); A61P 5/18 (2006.01); C07C 211/30 (2006.01); C07C 217/48 (2006.01); C07C 217/58 (2006.01); C07C 227/18 (2006.01); C07C 229/34 (2006.01); C07C 229/38 (2006.01); C07C 317/32 (2006.01); C07D 207/06 (2006.01); C07D 295/135 (2006.01); C07C 209/22 (2006.01); C07C 213/08 (2006.01); C07C 315/04 (2006.01); C07D 305/08 (2006.01); C07C 227/10 (2006.01); C07C 237/20 (2006.01);
U.S. Cl.
CPC ...
C07C 211/30 (2013.01); A61K 31/137 (2013.01); A61K 31/195 (2013.01); A61K 31/415 (2013.01); C07C 209/22 (2013.01); C07C 213/08 (2013.01); C07C 217/58 (2013.01); C07C 227/10 (2013.01); C07C 227/18 (2013.01); C07C 229/34 (2013.01); C07C 229/38 (2013.01); C07C 237/20 (2013.01); C07C 315/04 (2013.01); C07C 317/32 (2013.01); C07D 231/12 (2013.01); C07D 295/135 (2013.01); C07D 305/08 (2013.01);
Abstract

The invention relates to naphthalene compounds of Formula (I) and their pharmaceutically acceptable salts, wherein the substituents are as described herein, and their use in medicine for the treatment of diseases, disorders associated with the modulation of calcium sensing receptor modulators (Ca SR). The invention also relates to pharmaceutical compositions containing such compounds in treating diseases disorders associated with calcium sensing receptor modulators (Ca SR) channel modulators.

Find Patent Forward Citations

Loading…